======= C12orf49 ======= == Gene Information == * **Official Symbol**: C12orf49 * **Official Name**: chromosome 12 open reading frame 49 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79794|79794]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H741|Q9H741]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C12orf49&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C12orf49|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |DUF2054| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-4.96| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-4.09| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-3.03| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.54| |[[:results:exp483|FTY720 3μM R08 exp483]]|-1.86| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.77| |[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.72| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|1.77| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|1.84| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|1.95| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.98| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.12| |[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|2.8| |[[:results:exp180|Dynasore 10μM R04 exp180]]|2.87| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|3.41| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|3.66| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|5.68| ^Gene^Correlation^ |[[:human genes:s:scap|SCAP]]|0.511| |[[:human genes:u:unc50|UNC50]]|0.435| |[[:human genes:s:srebf2|SREBF2]]|0.414| Global Fraction of Cell Lines Where Essential: 5/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18982 * **Expression level (log2 read counts)**: 6.65 {{:chemogenomics:nalm6 dist.png?nolink |}}